Related Experiment Video
Updated: Jun 20, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Experimental antipsychotics and metabolic adverse effects--findings from clinical trials
Alexander Tschoner1, W Wolfgang Fleischhacker, Christoph F Ebenbichler
1Department of Internal Medicine I, Medical University Innsbruck, Center of Internal Medicine, 6020 Innsbruck, Austria. Christoph.Ebenbichler@i-med.ac.at
Abstract:
Initial optimism regarding the introduction of second-generation antipsychotic drugs has decreased because of accumulating concerns regarding efficacy and safety issues, particularly in terms of weight gain and disturbances in glucose and lipid metabolism. These adverse effects, in addition to posing serious health risks, significantly compromise patient compliance and contribute to overall lack of therapy effectiveness. Consequently, research efforts have been directed toward the development of new pharmacological treatment options for schizophrenia and bipolar disorder that are both efficacious and well tolerated. This review discusses some of the most recently developed antipsychotic compounds that have undergone clinical assessment from the perspective of their metabolic impact.
Related Concept Videos
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis and Antipsychotic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Typical and Atypical Agents
Mania and Antimanic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
